BANK VONTOBEL/CALL/SANOFI/110/0.1/20.09.24 Share Price

Warrant

DE000VM3T1L6

Market Closed - Deutsche Boerse AG 19:03:20 23/05/2024 BST
0.022 EUR -21.43% Intraday chart for BANK VONTOBEL/CALL/SANOFI/110/0.1/20.09.24
Current month-31.25%
1 month-24.14%
Date Price Change
23/05/24 0.022 -21.43%
22/05/24 0.028 +40.00%
21/05/24 0.02 -4.76%
20/05/24 0.021 -12.50%
17/05/24 0.024 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 07:03 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM3T1L
ISINDE000VM3T1L6
Date issued 10/10/2023
Strike 110
Maturity 20/09/2024 (120 Days)
Parity 10 : 1
Emission price 0.52
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.61
Lowest since issue 0.008
Spread 0.01
Spread %30.30%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
90.16 EUR
Average target price
108.2 EUR
Spread / Average Target
+20.00%
Consensus